Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

New Wearable Helps Smokers Kick the Habit

Posted on October 5th, 2016 by in Pharma R&D

The San Francisco-based biotech startup Chrono Therapeutics, a self-described “pioneer in digital drug therapy,” has just announced that it has successfully raised $47.6 million in Series B financing from a global array of investors. Continue reading “New Wearable Helps Smokers Kick the Habit” »

DEA Says No to Schedule II for Marijuana

Posted on September 5th, 2016 by in Pharma R&D

This month, in response to petitions from the former governors of Rhode Island and Washington and from a psychiatric nurse in New Mexico, the U.S. Drug Enforcement Agency (DEA) announced its decision to keep marijuana classified as a Schedule I controlled substance. Continue reading “DEA Says No to Schedule II for Marijuana” »

Reaching Out to Potential Drug Trial Participants

Posted on August 15th, 2016 by in Pharma R&D

Product testing is a necessary step in almost any industry, but in the pharmaceutical world, testing the safety and efficacy of drugs isn’t just a matter of getting a few people to ‘try it out’ – it’s a massive, tightly-regulated effort requiring extensive drug trials that include hundreds or thousands of participants. Continue reading “Reaching Out to Potential Drug Trial Participants” »

Does improving pre-clinical research reduce late-stage failures and improve R&D productivity?

Posted on January 12th, 2016 by in Pharma R&D

It’s the turn of the year and if you’re like me, you’ve been immersed in reading all of the accompanying look back and look ahead articles and reports. 2015 was, indeed, a notable year — from the Martin Shkreli fiasco to the proposed Pfizer and Allergan merger — the industry was rocked. Continue reading “Does improving pre-clinical research reduce late-stage failures and improve R&D productivity?” »